EVS
Short position disclosed on August 27, 2026.
0.89% of the capital sold short
1 disclosing fund
5 disclosures on record
BE0003820371 ISIN code
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Aug 8Aug 19Aug 30Sep 10
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Advisors LLC | 0.89% | +0.09 pt | August 27, 2026 |
On the other side: the funds that hold EVS Titelia
Get the moves on EVS by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 27, 2026 | Citadel Advisors LLC | 0.89% | still open |
| August 26, 2026 | Citadel Advisors LLC | 0.90% | |
| August 24, 2026 | Citadel Advisors LLC | 0.89% | |
| August 19, 2026 | Citadel Advisors LLC | 0.90% | |
| July 28, 2026 | Citadel Advisors LLC | 0.80% |
Download 5 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Belgium
- Solvay 1.39% of the capital sold short
- Biocartis 1.21% of the capital sold short
- Umicore 1.20% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.79% of the capital sold short
- Syensqo 0.79% of the capital sold short
- Azelis 0.69% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- Montea 0.60% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, EVS, source FSMA, data as at August 27, 2026, https://www.quivad.com/action/evs